Oncternal Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Oncternal Therapeutics, Inc. Website Screenshot

http://www.oncternal.com

Oncternal Therapeutics, Inc. Company Intro

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.

Industry

Healthcare

Oncternal Therapeutics, Inc. Headquaters

12230 El Camino Real
San Diego,92130
United States


Oncternal Therapeutics, Inc. Share price

18 Jun 2021 02:19 GMT

$5.34

-0.04 (-0.74 %)


Oncternal Therapeutics, Inc. Market cap

$260.147 M


WMC RANKING

2021

Oncternal Therapeutics, Inc. # 239

Biotechnology

Latest Oncternal Therapeutics, Inc. News

News 12 Jun 2021

Oncternal Therapeutics Inc (ONCT) falls -0.7330% for June 11

Oncternal Therapeutics Inc (NASDAQ: ONCT) shares fell -0.7330% to end trading Friday at $5.42 per share - a net change of $-0.04. Shares traded between ...

News 12 Jun 2021

Oncternal Therapeutics Inc. (NASDAQ: ONCT): What Matters ...

Oncternal Therapeutics Inc. (NASDAQ:ONCT) shares, rose in value on Friday, June 11, with the stock price down by -0.73% to the previous day's close as strong ...

News 09 Jun 2021

Sorrentos COVID Test Approved in Mexico

This and other recent developments involving Sorrento Therapeutics' pipeline and ... Kolbert reported Sorrento Therapeutics Inc. (SRNE:NASDAQ) discussed a number of ... Data from two of Oncternal Therapeutics' clinical trials in oncological ...


WMC Market Score


WMC Market to Revenue Score


Oncternal Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Oncternal Therapeutics, Inc. USD $2,425 $35,533 $-34,188 $2,656M 239
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $557,730B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $485,350B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $399,050B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $182,760B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors




Oncternal Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Oncternal Therapeutics, Inc. 0.03 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 24.00 15.82 100 0 0 53.75
Vertex Pharmaceuticals Incorporated 67.14 35.02 8.75 86 0 0 49.82
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.93 0.02 2 0 0 2.84

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries